PEG-PLA Nanoformulation for Breast Cancer Therapy
Worldwide, breast cancer is the second most common type of cancer among women next to lung cancer. Recurrence is seen in 30% of patients treated in their early stages of breast cancer due to therapeutic inefficiency. Breast cancer accounts for 25% of women cancer patients. The major drawback of drug...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English English |
| Published: |
Society for Biomaterials and Artificial Organs, India
2022
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/35006/1/TIBAO%202022%20nano%20chitosan.pdf http://umpir.ump.edu.my/id/eprint/35006/7/PEG-PLA%20Nanoformulation%20for%20Breast%20Cancer%20Therapy.pdf |